

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transport (GO:0015893) | 8.66912949 |
| 2 | organic cation transport (GO:0015695) | 8.41877425 |
| 3 | lysine metabolic process (GO:0006553) | 8.35784490 |
| 4 | lysine catabolic process (GO:0006554) | 8.35784490 |
| 5 | phosphate ion transport (GO:0006817) | 7.90645007 |
| 6 | quaternary ammonium group transport (GO:0015697) | 6.81298867 |
| 7 | glyoxylate metabolic process (GO:0046487) | 6.69740040 |
| 8 | response to mercury ion (GO:0046689) | 6.68184335 |
| 9 | behavioral response to nicotine (GO:0035095) | 6.66695614 |
| 10 | drug catabolic process (GO:0042737) | 6.63881449 |
| 11 | exogenous drug catabolic process (GO:0042738) | 6.53895405 |
| 12 | phosphate ion transmembrane transport (GO:0035435) | 6.35580240 |
| 13 | cysteine metabolic process (GO:0006534) | 6.21564902 |
| 14 | excretion (GO:0007588) | 6.17605965 |
| 15 | tricarboxylic acid metabolic process (GO:0072350) | 5.95276660 |
| 16 | short-chain fatty acid metabolic process (GO:0046459) | 5.74839453 |
| 17 | aspartate family amino acid catabolic process (GO:0009068) | 5.64437581 |
| 18 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.49411915 |
| 19 | renal absorption (GO:0070293) | 5.43471800 |
| 20 | branched-chain amino acid metabolic process (GO:0009081) | 5.31825546 |
| 21 | vitamin D metabolic process (GO:0042359) | 5.24112903 |
| 22 | toxin transport (GO:1901998) | 5.23985075 |
| 23 | trivalent inorganic anion homeostasis (GO:0072506) | 5.20276546 |
| 24 | phosphate ion homeostasis (GO:0055062) | 5.20276546 |
| 25 | sulfation (GO:0051923) | 5.15814549 |
| 26 | homocysteine metabolic process (GO:0050667) | 5.15364243 |
| 27 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.15167478 |
| 28 | valine metabolic process (GO:0006573) | 5.11245619 |
| 29 | proline metabolic process (GO:0006560) | 5.01528498 |
| 30 | amino-acid betaine transport (GO:0015838) | 4.89161232 |
| 31 | carnitine transport (GO:0015879) | 4.89161232 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.87430604 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 4.87430604 |
| 34 | aromatic amino acid family catabolic process (GO:0009074) | 4.83859880 |
| 35 | metanephric nephron tubule development (GO:0072234) | 4.83796553 |
| 36 | metanephric tubule development (GO:0072170) | 4.83796553 |
| 37 | glutathione biosynthetic process (GO:0006750) | 4.83778935 |
| 38 | modified amino acid transport (GO:0072337) | 4.82234321 |
| 39 | indole-containing compound catabolic process (GO:0042436) | 4.81459946 |
| 40 | indolalkylamine catabolic process (GO:0046218) | 4.81459946 |
| 41 | tryptophan catabolic process (GO:0006569) | 4.81459946 |
| 42 | L-phenylalanine catabolic process (GO:0006559) | 4.77156730 |
| 43 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.77156730 |
| 44 | glycoside metabolic process (GO:0016137) | 4.77102668 |
| 45 | cellular modified amino acid catabolic process (GO:0042219) | 4.70025681 |
| 46 | tryptophan metabolic process (GO:0006568) | 4.57668699 |
| 47 | serine family amino acid catabolic process (GO:0009071) | 4.55849693 |
| 48 | fructose metabolic process (GO:0006000) | 4.46873703 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 4.44874281 |
| 50 | metanephric nephron epithelium development (GO:0072243) | 4.42860096 |
| 51 | fatty acid beta-oxidation (GO:0006635) | 4.38733468 |
| 52 | serine family amino acid metabolic process (GO:0009069) | 4.38206681 |
| 53 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.35926157 |
| 54 | branched-chain amino acid catabolic process (GO:0009083) | 4.35712334 |
| 55 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.31976136 |
| 56 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.31976136 |
| 57 | amino-acid betaine metabolic process (GO:0006577) | 4.23863387 |
| 58 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.21237527 |
| 59 | fatty acid oxidation (GO:0019395) | 4.13021671 |
| 60 | acetyl-CoA metabolic process (GO:0006084) | 4.11808838 |
| 61 | NADH metabolic process (GO:0006734) | 4.09190237 |
| 62 | oligosaccharide catabolic process (GO:0009313) | 4.07860124 |
| 63 | cellular response to exogenous dsRNA (GO:0071360) | 4.07226776 |
| 64 | lipid oxidation (GO:0034440) | 4.04723412 |
| 65 | peptide biosynthetic process (GO:0043043) | 4.03925920 |
| 66 | metanephric epithelium development (GO:0072207) | 4.03488354 |
| 67 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.97840232 |
| 68 | peptide catabolic process (GO:0043171) | 3.94885875 |
| 69 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.91837709 |
| 70 | response to phenylpropanoid (GO:0080184) | 3.88869105 |
| 71 | positive regulation of fatty acid oxidation (GO:0046321) | 3.88662512 |
| 72 | nephron tubule development (GO:0072080) | 3.85817160 |
| 73 | polyol transport (GO:0015791) | 3.85554274 |
| 74 | response to parathyroid hormone (GO:0071107) | 3.83358065 |
| 75 | glutamate metabolic process (GO:0006536) | 3.83209763 |
| 76 | carnitine metabolic process (GO:0009437) | 3.82909427 |
| 77 | indole-containing compound metabolic process (GO:0042430) | 3.75715293 |
| 78 | cellular amino acid catabolic process (GO:0009063) | 3.74500435 |
| 79 | sodium-independent organic anion transport (GO:0043252) | 3.74070361 |
| 80 | kynurenine metabolic process (GO:0070189) | 3.73462964 |
| 81 | vitamin transport (GO:0051180) | 3.72675752 |
| 82 | fatty acid catabolic process (GO:0009062) | 3.70351329 |
| 83 | cellular ketone body metabolic process (GO:0046950) | 3.69023132 |
| 84 | response to growth hormone (GO:0060416) | 3.62408146 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 3.62364343 |
| 86 | aromatic amino acid family metabolic process (GO:0009072) | 3.59470693 |
| 87 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.57723510 |
| 88 | glutathione metabolic process (GO:0006749) | 3.57442521 |
| 89 | beta-amyloid metabolic process (GO:0050435) | 3.52650661 |
| 90 | serine family amino acid biosynthetic process (GO:0009070) | 3.52613945 |
| 91 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.52468062 |
| 92 | hydrogen peroxide catabolic process (GO:0042744) | 3.49627001 |
| 93 | monocarboxylic acid catabolic process (GO:0072329) | 3.44023762 |
| 94 | carboxylic acid catabolic process (GO:0046395) | 3.42969246 |
| 95 | organic acid catabolic process (GO:0016054) | 3.42969246 |
| 96 | cell proliferation in forebrain (GO:0021846) | 3.41330035 |
| 97 | indolalkylamine metabolic process (GO:0006586) | 3.40493787 |
| 98 | renal tubule development (GO:0061326) | 3.40282701 |
| 99 | benzene-containing compound metabolic process (GO:0042537) | 3.37180953 |
| 100 | sulfur compound transport (GO:0072348) | 3.37093672 |
| 101 | protein K48-linked deubiquitination (GO:0071108) | 3.36339899 |
| 102 | tricarboxylic acid cycle (GO:0006099) | 3.34898513 |
| 103 | sulfur amino acid catabolic process (GO:0000098) | 3.34422926 |
| 104 | alkaloid metabolic process (GO:0009820) | 3.34124532 |
| 105 | succinate metabolic process (GO:0006105) | 3.33314500 |
| 106 | drug metabolic process (GO:0017144) | 3.32943975 |
| 107 | glutathione derivative biosynthetic process (GO:1901687) | 3.32552067 |
| 108 | glutathione derivative metabolic process (GO:1901685) | 3.32552067 |
| 109 | protein complex biogenesis (GO:0070271) | 3.30428979 |
| 110 | sodium ion transport (GO:0006814) | 3.29142686 |
| 111 | dicarboxylic acid metabolic process (GO:0043648) | 3.25921663 |
| 112 | membrane repolarization during action potential (GO:0086011) | 3.25872210 |
| 113 | oxaloacetate metabolic process (GO:0006107) | 3.25855800 |
| 114 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.22499958 |
| 115 | L-fucose catabolic process (GO:0042355) | 3.22174966 |
| 116 | fucose catabolic process (GO:0019317) | 3.22174966 |
| 117 | L-fucose metabolic process (GO:0042354) | 3.22174966 |
| 118 | activated T cell proliferation (GO:0050798) | 3.21998974 |
| 119 | regulation of guanylate cyclase activity (GO:0031282) | 3.19074362 |
| 120 | flavonoid metabolic process (GO:0009812) | 3.14313926 |
| 121 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.09429864 |
| 122 | cardiovascular system development (GO:0072358) | 3.09076830 |
| 123 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.08451694 |
| 124 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.08451694 |
| 125 | NADH dehydrogenase complex assembly (GO:0010257) | 3.08451694 |
| 126 | cellular response to ATP (GO:0071318) | 3.08024373 |
| 127 | cellular anion homeostasis (GO:0030002) | 3.06959894 |
| 128 | positive regulation of fatty acid transport (GO:2000193) | 3.06578973 |
| 129 | serotonin metabolic process (GO:0042428) | 3.04481306 |
| 130 | regulation of triglyceride catabolic process (GO:0010896) | 2.96445368 |
| 131 | primary amino compound metabolic process (GO:1901160) | 2.95791694 |
| 132 | dentate gyrus development (GO:0021542) | 2.93620230 |
| 133 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.92354551 |
| 134 | DNA deamination (GO:0045006) | 2.89460511 |
| 135 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.88167565 |
| 136 | kidney morphogenesis (GO:0060993) | 2.83282444 |
| 137 | cobalamin metabolic process (GO:0009235) | 2.82776257 |
| 138 | gamma-aminobutyric acid transport (GO:0015812) | 2.80721662 |
| 139 | vitamin biosynthetic process (GO:0009110) | 2.79994455 |
| 140 | protein import into peroxisome matrix (GO:0016558) | 2.77044326 |
| 141 | angiotensin maturation (GO:0002003) | 2.73401557 |
| 142 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73080870 |
| 143 | diacylglycerol metabolic process (GO:0046339) | 2.71706673 |
| 144 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.64364907 |
| 145 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.62555783 |
| 146 | somite development (GO:0061053) | 2.61016454 |
| 147 | transepithelial transport (GO:0070633) | 2.60918484 |
| 148 | head development (GO:0060322) | 2.60373532 |
| 149 | auditory receptor cell differentiation (GO:0042491) | 2.59894602 |
| 150 | interferon-gamma secretion (GO:0072643) | 2.59538671 |
| 151 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.59324463 |
| 152 | parturition (GO:0007567) | 2.57451995 |
| 153 | negative regulation of response to food (GO:0032096) | 2.56976513 |
| 154 | negative regulation of appetite (GO:0032099) | 2.56976513 |
| 155 | protein polyglutamylation (GO:0018095) | 2.53510431 |
| 156 | urinary tract smooth muscle contraction (GO:0014848) | 2.52173830 |
| 157 | vitamin A metabolic process (GO:0006776) | 2.51286419 |
| 158 | positive regulation of defense response to virus by host (GO:0002230) | 2.50192873 |
| 159 | ovulation cycle (GO:0042698) | 2.49416975 |
| 160 | nephron tubule morphogenesis (GO:0072078) | 2.46747828 |
| 161 | nephron epithelium morphogenesis (GO:0072088) | 2.46747828 |
| 162 | sulfate transmembrane transport (GO:1902358) | 2.45522913 |
| 163 | positive regulation of icosanoid secretion (GO:0032305) | 2.44722428 |
| 164 | cytidine deamination (GO:0009972) | 2.43750716 |
| 165 | cytidine metabolic process (GO:0046087) | 2.43750716 |
| 166 | cytidine catabolic process (GO:0006216) | 2.43750716 |
| 167 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.43377475 |
| 168 | regulation of action potential (GO:0098900) | 2.41098000 |
| 169 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.40003006 |
| 170 | detection of light stimulus involved in visual perception (GO:0050908) | 2.40003006 |
| 171 | spinal cord motor neuron differentiation (GO:0021522) | 2.38537692 |
| 172 | dendritic spine morphogenesis (GO:0060997) | 2.38288843 |
| 173 | neuronal action potential (GO:0019228) | 2.34533535 |
| 174 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.34412592 |
| 175 | positive regulation of histone deacetylation (GO:0031065) | 2.34202968 |
| 176 | nucleobase catabolic process (GO:0046113) | 2.32807514 |
| 177 | transmission of nerve impulse (GO:0019226) | 2.32788353 |
| 178 | limb development (GO:0060173) | 2.32290419 |
| 179 | appendage development (GO:0048736) | 2.32290419 |
| 180 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.30856533 |
| 181 | membrane depolarization during action potential (GO:0086010) | 2.29739470 |
| 182 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.28372943 |
| 183 | tachykinin receptor signaling pathway (GO:0007217) | 2.28198759 |
| 184 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.28071438 |
| 185 | presynaptic membrane assembly (GO:0097105) | 2.27844368 |
| 186 | regulation of synapse maturation (GO:0090128) | 2.26279367 |
| 187 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.25409521 |
| 188 | regulation of hippo signaling (GO:0035330) | 2.25014989 |
| 189 | negative regulation of membrane potential (GO:0045837) | 2.24843291 |
| 190 | oxidative demethylation (GO:0070989) | 2.23177288 |
| 191 | magnesium ion transport (GO:0015693) | 2.23069956 |
| 192 | aminoglycoside antibiotic metabolic process (GO:0030647) | 10.9660513 |
| 193 | drug transmembrane transport (GO:0006855) | 10.2357471 |
| 194 | urate metabolic process (GO:0046415) | 10.0703031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.05325951 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.35749317 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.19105199 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.38725798 |
| 5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.95267461 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.80463331 |
| 7 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.77232152 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.00886192 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.74256605 |
| 10 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.73104782 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.57561261 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.53461525 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.41274671 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.41186296 |
| 15 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.36350682 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.35487361 |
| 17 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.30300450 |
| 18 | * AR_21909140_ChIP-Seq_LNCAP_Human | 2.23782308 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.21473673 |
| 20 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.09224479 |
| 21 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.07537085 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.07054027 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03053811 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02534219 |
| 25 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.00920160 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99982461 |
| 27 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.98920147 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94411684 |
| 29 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.92029095 |
| 30 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.91936265 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.90921555 |
| 32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.89897029 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89624554 |
| 34 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.88799615 |
| 35 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.84334037 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.83829438 |
| 37 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.83681059 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.82411209 |
| 39 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.78539858 |
| 40 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.77877119 |
| 41 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.72548450 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.65440756 |
| 43 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.64163144 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.63868338 |
| 45 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63311894 |
| 46 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.60269248 |
| 47 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.58387871 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.57622390 |
| 49 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.53848788 |
| 50 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.52602696 |
| 51 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52590185 |
| 52 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52336376 |
| 53 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52022191 |
| 54 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.51849585 |
| 55 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.46714337 |
| 56 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.41933434 |
| 57 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.41182477 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40598194 |
| 59 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.40230524 |
| 60 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.40230524 |
| 61 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.36923562 |
| 62 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.36891502 |
| 63 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.36701602 |
| 64 | ERA_21632823_ChIP-Seq_H3396_Human | 1.36118728 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.33861883 |
| 66 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.33307920 |
| 67 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.32956631 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.31942095 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31269045 |
| 70 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.30616410 |
| 71 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30242367 |
| 72 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.30232122 |
| 73 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29867819 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29583900 |
| 75 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.29164670 |
| 76 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.28262993 |
| 77 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.26953913 |
| 78 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26630389 |
| 79 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.26102647 |
| 80 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25885966 |
| 81 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.24466911 |
| 82 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.22583945 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21810909 |
| 84 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.18762364 |
| 85 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18762364 |
| 86 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.18665079 |
| 87 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16275046 |
| 88 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.15541950 |
| 89 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.15297064 |
| 90 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.14740080 |
| 91 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14641717 |
| 92 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.13879402 |
| 93 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13244327 |
| 94 | * NCOR_22424771_ChIP-Seq_293T_Human | 1.13013939 |
| 95 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.12877653 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.12455936 |
| 97 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.11119405 |
| 98 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10270242 |
| 99 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09647393 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.09443356 |
| 101 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.08774665 |
| 102 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08699348 |
| 103 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08333431 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07633563 |
| 105 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07633563 |
| 106 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06945110 |
| 107 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.05045260 |
| 108 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.04484947 |
| 109 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.04429515 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04235446 |
| 111 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.03396047 |
| 112 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.03185491 |
| 113 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.02646062 |
| 114 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02256423 |
| 115 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02184323 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.01437684 |
| 117 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01401381 |
| 118 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.99877932 |
| 119 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.99549030 |
| 120 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.99549030 |
| 121 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.99393872 |
| 122 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.99028540 |
| 123 | EWS_26573619_Chip-Seq_HEK293_Human | 0.99014697 |
| 124 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98039129 |
| 125 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.97937827 |
| 126 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.97235233 |
| 127 | * PHF8_20622854_ChIP-Seq_HELA_Human | 0.96476138 |
| 128 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.96065586 |
| 129 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95756033 |
| 130 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.94834113 |
| 131 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.94499598 |
| 132 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94397102 |
| 133 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.94297501 |
| 134 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.94296903 |
| 135 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94234334 |
| 136 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.94205957 |
| 137 | * P68_20966046_ChIP-Seq_HELA_Human | 0.92970215 |
| 138 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92837627 |
| 139 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92705569 |
| 140 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.92123682 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.92009118 |
| 142 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.91167326 |
| 143 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91075574 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90662363 |
| 145 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90319206 |
| 146 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89568820 |
| 147 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.88894744 |
| 148 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.88713824 |
| 149 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.88664032 |
| 150 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.88643364 |
| 151 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.88531044 |
| 152 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.87574238 |
| 153 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.86506285 |
| 154 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.84839071 |
| 155 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.84324941 |
| 156 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.83504347 |
| 157 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83265645 |
| 158 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81825712 |
| 159 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.80471269 |
| 160 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.76961603 |
| 161 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76713109 |
| 162 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.76060824 |
| 163 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75826287 |
| 164 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75203882 |
| 165 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74891971 |
| 166 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.74804186 |
| 167 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.73978338 |
| 168 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73050506 |
| 169 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.72716655 |
| 170 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.72338927 |
| 171 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.71927723 |
| 172 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.71905566 |
| 173 | AR_20517297_ChIP-Seq_VCAP_Human | 0.71825189 |
| 174 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.70987824 |
| 175 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.70884696 |
| 176 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.70806435 |
| 177 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70732819 |
| 178 | GATA2_19941826_ChIP-Seq_K562_Human | 0.70072595 |
| 179 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69198281 |
| 180 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.68815826 |
| 181 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.68448800 |
| 182 | * TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68009347 |
| 183 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.66560730 |
| 184 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.66355736 |
| 185 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.66261947 |
| 186 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.65812412 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.93011605 |
| 2 | MP0004043_abnormal_pH_regulation | 6.64640631 |
| 3 | MP0004019_abnormal_vitamin_homeostasis | 5.11887172 |
| 4 | * MP0005332_abnormal_amino_acid | 4.73191117 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.63751531 |
| 6 | MP0001765_abnormal_ion_homeostasis | 4.04851218 |
| 7 | MP0009643_abnormal_urine_homeostasis | 4.03188823 |
| 8 | MP0003195_calcinosis | 3.73091411 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.44738651 |
| 10 | MP0005636_abnormal_mineral_homeostasis | 3.28531293 |
| 11 | MP0001756_abnormal_urination | 3.16514849 |
| 12 | MP0003878_abnormal_ear_physiology | 2.98627691 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.98627691 |
| 14 | MP0008875_abnormal_xenobiotic_pharmacok | 2.88768416 |
| 15 | * MP0002136_abnormal_kidney_physiology | 2.87002746 |
| 16 | MP0001958_emphysema | 2.52664929 |
| 17 | MP0001968_abnormal_touch/_nociception | 2.31305414 |
| 18 | MP0003252_abnormal_bile_duct | 2.28570720 |
| 19 | MP0005365_abnormal_bile_salt | 2.27728910 |
| 20 | MP0001986_abnormal_taste_sensitivity | 2.20217945 |
| 21 | MP0004130_abnormal_muscle_cell | 2.18040914 |
| 22 | MP0005058_abnormal_lysosome_morphology | 2.14780369 |
| 23 | MP0005085_abnormal_gallbladder_physiolo | 2.12522399 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 2.01501382 |
| 25 | MP0009379_abnormal_foot_pigmentation | 1.99138712 |
| 26 | MP0005174_abnormal_tail_pigmentation | 1.95930353 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.95542566 |
| 28 | MP0004885_abnormal_endolymph | 1.86321540 |
| 29 | MP0000538_abnormal_urinary_bladder | 1.83997936 |
| 30 | MP0002735_abnormal_chemical_nociception | 1.83790302 |
| 31 | MP0004133_heterotaxia | 1.75721390 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.73434538 |
| 33 | MP0002736_abnormal_nociception_after | 1.70222238 |
| 34 | MP0006292_abnormal_olfactory_placode | 1.69349672 |
| 35 | MP0008872_abnormal_physiological_respon | 1.68629122 |
| 36 | MP0005646_abnormal_pituitary_gland | 1.68029290 |
| 37 | MP0005551_abnormal_eye_electrophysiolog | 1.66992018 |
| 38 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65764362 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.62654174 |
| 40 | MP0001188_hyperpigmentation | 1.60873975 |
| 41 | MP0003186_abnormal_redox_activity | 1.60120777 |
| 42 | MP0005451_abnormal_body_composition | 1.54221053 |
| 43 | MP0000631_abnormal_neuroendocrine_gland | 1.46345135 |
| 44 | MP0003136_yellow_coat_color | 1.45871080 |
| 45 | MP0003787_abnormal_imprinting | 1.44994022 |
| 46 | MP0004142_abnormal_muscle_tone | 1.44423384 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.40160856 |
| 48 | MP0005319_abnormal_enzyme/_coenzyme | 1.39974044 |
| 49 | MP0002272_abnormal_nervous_system | 1.39231555 |
| 50 | MP0002733_abnormal_thermal_nociception | 1.37744100 |
| 51 | MP0000049_abnormal_middle_ear | 1.37190803 |
| 52 | MP0001970_abnormal_pain_threshold | 1.36101070 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.32657397 |
| 54 | MP0002160_abnormal_reproductive_system | 1.29493201 |
| 55 | MP0002638_abnormal_pupillary_reflex | 1.29159100 |
| 56 | MP0004145_abnormal_muscle_electrophysio | 1.28597615 |
| 57 | MP0008877_abnormal_DNA_methylation | 1.27604932 |
| 58 | MP0002896_abnormal_bone_mineralization | 1.27375237 |
| 59 | MP0001666_abnormal_nutrient_absorption | 1.27264696 |
| 60 | MP0002822_catalepsy | 1.27193487 |
| 61 | MP0001486_abnormal_startle_reflex | 1.26943681 |
| 62 | MP0003011_delayed_dark_adaptation | 1.26499130 |
| 63 | MP0000230_abnormal_systemic_arterial | 1.25320646 |
| 64 | MP0009745_abnormal_behavioral_response | 1.24792798 |
| 65 | MP0002876_abnormal_thyroid_physiology | 1.24547850 |
| 66 | MP0005084_abnormal_gallbladder_morpholo | 1.23065608 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.20587987 |
| 68 | MP0008775_abnormal_heart_ventricle | 1.19783868 |
| 69 | MP0000026_abnormal_inner_ear | 1.19561719 |
| 70 | MP0003183_abnormal_peptide_metabolism | 1.19330585 |
| 71 | MP0000537_abnormal_urethra_morphology | 1.17402068 |
| 72 | MP0003806_abnormal_nucleotide_metabolis | 1.15669192 |
| 73 | MP0002168_other_aberrant_phenotype | 1.15495328 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 1.15148109 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 1.14287859 |
| 76 | MP0003122_maternal_imprinting | 1.12818062 |
| 77 | MP0002249_abnormal_larynx_morphology | 1.12541711 |
| 78 | MP0002928_abnormal_bile_duct | 1.11807055 |
| 79 | MP0004924_abnormal_behavior | 1.11434722 |
| 80 | MP0005386_behavior/neurological_phenoty | 1.11434722 |
| 81 | MP0005448_abnormal_energy_balance | 1.11128995 |
| 82 | MP0005389_reproductive_system_phenotype | 1.10873981 |
| 83 | MP0001440_abnormal_grooming_behavior | 1.10585715 |
| 84 | MP0005671_abnormal_response_to | 1.10329186 |
| 85 | MP0003890_abnormal_embryonic-extraembry | 1.09740420 |
| 86 | MP0002064_seizures | 1.08748052 |
| 87 | MP0001502_abnormal_circadian_rhythm | 1.08335294 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 1.07896393 |
| 89 | MP0001905_abnormal_dopamine_level | 1.07121060 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 1.05854022 |
| 91 | MP0001764_abnormal_homeostasis | 1.05548483 |
| 92 | MP0002102_abnormal_ear_morphology | 1.05447002 |
| 93 | MP0005535_abnormal_body_temperature | 1.04974896 |
| 94 | MP0004147_increased_porphyrin_level | 1.03915290 |
| 95 | MP0002734_abnormal_mechanical_nocicepti | 1.03338222 |
| 96 | MP0003866_abnormal_defecation | 1.02684694 |
| 97 | MP0001501_abnormal_sleep_pattern | 1.01316325 |
| 98 | MP0005670_abnormal_white_adipose | 1.00198045 |
| 99 | * MP0002135_abnormal_kidney_morphology | 0.99405978 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.96973816 |
| 101 | MP0003121_genomic_imprinting | 0.96948522 |
| 102 | MP0006072_abnormal_retinal_apoptosis | 0.96386426 |
| 103 | MP0005409_darkened_coat_color | 0.94461149 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.94041778 |
| 105 | MP0003123_paternal_imprinting | 0.93403419 |
| 106 | MP0000427_abnormal_hair_cycle | 0.92848078 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.92779171 |
| 108 | MP0003938_abnormal_ear_development | 0.90970002 |
| 109 | MP0005423_abnormal_somatic_nervous | 0.89723996 |
| 110 | MP0002118_abnormal_lipid_homeostasis | 0.88898745 |
| 111 | MP0001873_stomach_inflammation | 0.87766156 |
| 112 | MP0005220_abnormal_exocrine_pancreas | 0.86883835 |
| 113 | MP0002063_abnormal_learning/memory/cond | 0.86665539 |
| 114 | MP0003635_abnormal_synaptic_transmissio | 0.86161990 |
| 115 | MP0002938_white_spotting | 0.85706553 |
| 116 | MP0009384_cardiac_valve_regurgitation | 0.85225876 |
| 117 | MP0002752_abnormal_somatic_nervous | 0.83667230 |
| 118 | MP0000747_muscle_weakness | 0.82220815 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.81417132 |
| 120 | MP0003191_abnormal_cellular_cholesterol | 0.81358709 |
| 121 | MP0010234_abnormal_vibrissa_follicle | 0.81226921 |
| 122 | MP0002932_abnormal_joint_morphology | 0.80403016 |
| 123 | MP0003172_abnormal_lysosome_physiology | 0.78128046 |
| 124 | MP0003283_abnormal_digestive_organ | 0.76817405 |
| 125 | * MP0009642_abnormal_blood_homeostasis | 0.74602716 |
| 126 | MP0001485_abnormal_pinna_reflex | 0.71170710 |
| 127 | MP0010329_abnormal_lipoprotein_level | 0.64077777 |
| 128 | MP0003646_muscle_fatigue | 0.63705718 |
| 129 | MP0004742_abnormal_vestibular_system | 0.60056575 |
| 130 | MP0002115_abnormal_skeleton_extremities | 0.60024581 |
| 131 | MP0000371_diluted_coat_color | 0.59851827 |
| 132 | MP0000609_abnormal_liver_physiology | 0.59519792 |
| 133 | MP0002796_impaired_skin_barrier | 0.59116976 |
| 134 | MP0005395_other_phenotype | 0.58865367 |
| 135 | MP0009780_abnormal_chondrocyte_physiolo | 0.57168427 |
| 136 | MP0001661_extended_life_span | 0.56565702 |
| 137 | MP0003795_abnormal_bone_structure | 0.54412759 |
| 138 | MP0003959_abnormal_lean_body | 0.52479265 |
| 139 | MP0004858_abnormal_nervous_system | 0.52467360 |
| 140 | MP0003329_amyloid_beta_deposits | 0.52159809 |
| 141 | MP0003879_abnormal_hair_cell | 0.51495419 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.51147282 |
| 143 | MP0000598_abnormal_liver_morphology | 0.51065277 |
| 144 | MP0005408_hypopigmentation | 0.50845853 |
| 145 | MP0008469_abnormal_protein_level | 0.49850644 |
| 146 | MP0001663_abnormal_digestive_system | 0.49772821 |
| 147 | MP0005165_increased_susceptibility_to | 0.49663727 |
| 148 | MP0003953_abnormal_hormone_level | 0.48952862 |
| 149 | MP0002069_abnormal_eating/drinking_beha | 0.47694756 |
| 150 | MP0004484_altered_response_of | 0.45507631 |
| 151 | MP0005501_abnormal_skin_physiology | 0.44830217 |
| 152 | MP0002098_abnormal_vibrissa_morphology | 0.44598525 |
| 153 | MP0002998_abnormal_bone_remodeling | 0.43068049 |
| 154 | MP0006035_abnormal_mitochondrial_morpho | 0.42199037 |
| 155 | MP0000163_abnormal_cartilage_morphology | 0.41796300 |
| 156 | MP0010386_abnormal_urinary_bladder | 0.41714946 |
| 157 | MP0000678_abnormal_parathyroid_gland | 0.40657140 |
| 158 | MP0005375_adipose_tissue_phenotype | 0.40415975 |
| 159 | MP0000534_abnormal_ureter_morphology | 0.39598884 |
| 160 | MP0009672_abnormal_birth_weight | 0.39476774 |
| 161 | MP0005166_decreased_susceptibility_to | 0.38845310 |
| 162 | MP0001664_abnormal_digestion | 0.38111921 |
| 163 | MP0001731_abnormal_postnatal_growth | 0.37708064 |
| 164 | MP0003221_abnormal_cardiomyocyte_apopto | 0.35829102 |
| 165 | MP0005381_digestive/alimentary_phenotyp | 0.35494415 |
| 166 | MP0004272_abnormal_basement_membrane | 0.34980908 |
| 167 | MP0003075_altered_response_to | 0.34327561 |
| 168 | MP0003315_abnormal_perineum_morphology | 0.32686237 |
| 169 | MP0004233_abnormal_muscle_weight | 0.31136652 |
| 170 | MP0001963_abnormal_hearing_physiology | 0.30892949 |
| 171 | MP0002113_abnormal_skeleton_development | 0.30029450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.96537353 |
| 2 | Metabolic alkalosis (HP:0200114) | 7.44226143 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 7.41579524 |
| 4 | Hypomagnesemia (HP:0002917) | 7.01427831 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 6.89002049 |
| 6 | Polyuria (HP:0000103) | 6.68381552 |
| 7 | Gout (HP:0001997) | 6.60747217 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 6.33071063 |
| 9 | Abnormal urine output (HP:0012590) | 6.28487827 |
| 10 | Abnormality of renal excretion (HP:0011036) | 6.03355949 |
| 11 | Abnormality of magnesium homeostasis (HP:0004921) | 5.94031853 |
| 12 | Abnormal drinking behavior (HP:0030082) | 5.54893661 |
| 13 | Polydipsia (HP:0001959) | 5.54893661 |
| 14 | Proximal tubulopathy (HP:0000114) | 5.47717120 |
| 15 | Abnormality of renin-angiotensin system (HP:0000847) | 4.92957799 |
| 16 | Increased purine levels (HP:0004368) | 4.85857826 |
| 17 | Hyperuricemia (HP:0002149) | 4.85857826 |
| 18 | Renal salt wasting (HP:0000127) | 4.82040308 |
| 19 | Alkalosis (HP:0001948) | 4.81592411 |
| 20 | Hyperglycinuria (HP:0003108) | 4.78452454 |
| 21 | Tetany (HP:0001281) | 4.77436961 |
| 22 | Hyperaldosteronism (HP:0000859) | 4.76900227 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.75644806 |
| 24 | Abnormality of purine metabolism (HP:0004352) | 4.29836176 |
| 25 | Generalized aminoaciduria (HP:0002909) | 4.16623451 |
| 26 | Genetic anticipation (HP:0003743) | 4.02307983 |
| 27 | Congenital stationary night blindness (HP:0007642) | 3.95581532 |
| 28 | Hypercalciuria (HP:0002150) | 3.92934578 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.90899828 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.90899828 |
| 31 | Hypokalemia (HP:0002900) | 3.77031059 |
| 32 | Abnormality of urine glucose concentration (HP:0011016) | 3.64446854 |
| 33 | Glycosuria (HP:0003076) | 3.64446854 |
| 34 | Renal tubular acidosis (HP:0001947) | 3.59050972 |
| 35 | Ketoacidosis (HP:0001993) | 3.54472701 |
| 36 | Cutaneous melanoma (HP:0012056) | 3.35793056 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 3.33805097 |
| 38 | Pancreatic cysts (HP:0001737) | 3.31192953 |
| 39 | Abnormality of proline metabolism (HP:0010907) | 3.24062981 |
| 40 | Hydroxyprolinuria (HP:0003080) | 3.24062981 |
| 41 | Hyperphosphaturia (HP:0003109) | 3.21372492 |
| 42 | Ketosis (HP:0001946) | 3.20423567 |
| 43 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.17639983 |
| 44 | Abnormality of potassium homeostasis (HP:0011042) | 3.16927030 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.13593294 |
| 46 | Congenital sensorineural hearing impairment (HP:0008527) | 3.05952660 |
| 47 | Clumsiness (HP:0002312) | 3.05457613 |
| 48 | Abnormal urine phosphate concentration (HP:0012599) | 3.02669085 |
| 49 | Delayed epiphyseal ossification (HP:0002663) | 3.02103502 |
| 50 | Abnormality of vitamin B metabolism (HP:0004340) | 2.98387310 |
| 51 | Methylmalonic acidemia (HP:0002912) | 2.94273539 |
| 52 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.87837884 |
| 53 | Nephronophthisis (HP:0000090) | 2.87635456 |
| 54 | Nephrocalcinosis (HP:0000121) | 2.87612684 |
| 55 | Pancreatic fibrosis (HP:0100732) | 2.82738325 |
| 56 | Molar tooth sign on MRI (HP:0002419) | 2.79068984 |
| 57 | Abnormality of midbrain morphology (HP:0002418) | 2.79068984 |
| 58 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.78055274 |
| 59 | Short 4th metacarpal (HP:0010044) | 2.78055274 |
| 60 | Pendular nystagmus (HP:0012043) | 2.77559058 |
| 61 | True hermaphroditism (HP:0010459) | 2.75582602 |
| 62 | Short femoral neck (HP:0100864) | 2.74217038 |
| 63 | Nephrolithiasis (HP:0000787) | 2.72203270 |
| 64 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.70680269 |
| 65 | Hyperventilation (HP:0002883) | 2.69205583 |
| 66 | Hyperglycinemia (HP:0002154) | 2.66698926 |
| 67 | Hypophosphatemia (HP:0002148) | 2.63233151 |
| 68 | Vascular calcification (HP:0004934) | 2.61552066 |
| 69 | Widely patent fontanelles and sutures (HP:0004492) | 2.60794389 |
| 70 | Abolished electroretinogram (ERG) (HP:0000550) | 2.58482696 |
| 71 | Abnormality of the renal medulla (HP:0100957) | 2.56392987 |
| 72 | Abnormality of sodium homeostasis (HP:0010931) | 2.56219479 |
| 73 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.55241004 |
| 74 | Rickets (HP:0002748) | 2.51804968 |
| 75 | Meningioma (HP:0002858) | 2.50447774 |
| 76 | Dehydration (HP:0001944) | 2.49674324 |
| 77 | Vacuolated lymphocytes (HP:0001922) | 2.48725619 |
| 78 | Delayed CNS myelination (HP:0002188) | 2.48280700 |
| 79 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.48021674 |
| 80 | Hyponatremia (HP:0002902) | 2.47944701 |
| 81 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.47489082 |
| 82 | Metaphyseal cupping (HP:0003021) | 2.45374823 |
| 83 | Abnormality of renal resorption (HP:0011038) | 2.43878120 |
| 84 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.41916708 |
| 85 | Pigmentary retinal degeneration (HP:0001146) | 2.41229237 |
| 86 | Patellar aplasia (HP:0006443) | 2.40438192 |
| 87 | Cystic liver disease (HP:0006706) | 2.38830683 |
| 88 | Hyperammonemia (HP:0001987) | 2.38764218 |
| 89 | Chorioretinal atrophy (HP:0000533) | 2.36324254 |
| 90 | Cardiovascular calcification (HP:0011915) | 2.32619480 |
| 91 | Malnutrition (HP:0004395) | 2.31817178 |
| 92 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.31227312 |
| 93 | Dicarboxylic aciduria (HP:0003215) | 2.30681041 |
| 94 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.30681041 |
| 95 | Enlarged kidneys (HP:0000105) | 2.28529143 |
| 96 | Chronic hepatic failure (HP:0100626) | 2.25172923 |
| 97 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.24632188 |
| 98 | Metabolic acidosis (HP:0001942) | 2.23872132 |
| 99 | Vomiting (HP:0002013) | 2.23125475 |
| 100 | Confusion (HP:0001289) | 2.22361694 |
| 101 | Hypoplasia of the ulna (HP:0003022) | 2.21444162 |
| 102 | Renal tubular dysfunction (HP:0000124) | 2.21118456 |
| 103 | Abnormality of the renal cortex (HP:0011035) | 2.20231042 |
| 104 | Type II lissencephaly (HP:0007260) | 2.20216630 |
| 105 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.18839316 |
| 106 | Abnormality of the 4th metacarpal (HP:0010012) | 2.16681189 |
| 107 | Adrenal overactivity (HP:0002717) | 2.15734535 |
| 108 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.13945118 |
| 109 | Agitation (HP:0000713) | 2.10678468 |
| 110 | Decreased central vision (HP:0007663) | 2.10372551 |
| 111 | Rib fusion (HP:0000902) | 2.09663374 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09605589 |
| 113 | Thin bony cortex (HP:0002753) | 2.09300273 |
| 114 | Concave nail (HP:0001598) | 2.08623145 |
| 115 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.08087439 |
| 116 | Methylmalonic aciduria (HP:0012120) | 2.07823883 |
| 117 | Attenuation of retinal blood vessels (HP:0007843) | 2.07732799 |
| 118 | Stomach cancer (HP:0012126) | 2.06008098 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04061591 |
| 120 | Furrowed tongue (HP:0000221) | 2.02885704 |
| 121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.00827544 |
| 122 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.00529426 |
| 123 | Short tibia (HP:0005736) | 2.00015398 |
| 124 | Lethargy (HP:0001254) | 1.95520057 |
| 125 | Abnormal albumin level (HP:0012116) | 1.95496342 |
| 126 | Hypoalbuminemia (HP:0003073) | 1.95496342 |
| 127 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.94853792 |
| 128 | Decreased circulating renin level (HP:0003351) | 1.94830566 |
| 129 | Gaze-evoked nystagmus (HP:0000640) | 1.93760471 |
| 130 | Abnormality of the renal collecting system (HP:0004742) | 1.93755638 |
| 131 | Abnormal tarsal ossification (HP:0008369) | 1.93492039 |
| 132 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 1.93212637 |
| 133 | Hemiplegia (HP:0002301) | 1.93147751 |
| 134 | Absent thumb (HP:0009777) | 1.92215427 |
| 135 | Acanthocytosis (HP:0001927) | 1.88589581 |
| 136 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.88487718 |
| 137 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.88423053 |
| 138 | Osteomalacia (HP:0002749) | 1.88292215 |
| 139 | Abnormality of the costochondral junction (HP:0000919) | 1.88268551 |
| 140 | Sensorimotor neuropathy (HP:0007141) | 1.87726875 |
| 141 | Tubulointerstitial fibrosis (HP:0005576) | 1.87471834 |
| 142 | Hypoplasia of the pons (HP:0012110) | 1.86482198 |
| 143 | Chondrocalcinosis (HP:0000934) | 1.86438407 |
| 144 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.84446303 |
| 145 | Potter facies (HP:0002009) | 1.82630303 |
| 146 | Facial shape deformation (HP:0011334) | 1.82630303 |
| 147 | Short 1st metacarpal (HP:0010034) | 1.82295264 |
| 148 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.82295264 |
| 149 | Abnormality of the nasal septum (HP:0000419) | 1.82232714 |
| 150 | Abnormality of the 1st metacarpal (HP:0010009) | 1.80038710 |
| 151 | Irritability (HP:0000737) | 1.78849120 |
| 152 | Abnormality of DNA repair (HP:0003254) | 1.78050605 |
| 153 | Abnormality of vitamin metabolism (HP:0100508) | 1.77449578 |
| 154 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77018310 |
| 155 | Congenital, generalized hypertrichosis (HP:0004540) | 1.76909540 |
| 156 | Asplenia (HP:0001746) | 1.76895823 |
| 157 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.76782715 |
| 158 | Glomerulosclerosis (HP:0000096) | 1.75540878 |
| 159 | Increased corneal curvature (HP:0100692) | 1.75145952 |
| 160 | Keratoconus (HP:0000563) | 1.75145952 |
| 161 | Tubular atrophy (HP:0000092) | 1.74467926 |
| 162 | Lymphangioma (HP:0100764) | 1.74300558 |
| 163 | Enlarged epiphyses (HP:0010580) | 1.73982473 |
| 164 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.73980328 |
| 165 | Abnormality of Sharpey fibers (HP:0100685) | 1.73700428 |
| 166 | Protruding tongue (HP:0010808) | 1.73578904 |
| 167 | Impaired smooth pursuit (HP:0007772) | 1.72645025 |
| 168 | Abnormal number of erythroid precursors (HP:0012131) | 1.72236505 |
| 169 | Hypotension (HP:0002615) | 1.71167539 |
| 170 | Nausea (HP:0002018) | 1.70805482 |
| 171 | IgG deficiency (HP:0004315) | 1.69378429 |
| 172 | Metaphyseal irregularity (HP:0003025) | 1.69374265 |
| 173 | Hypoplasia of the radius (HP:0002984) | 1.67678783 |
| 174 | Short phalanx of the thumb (HP:0009660) | 1.66962914 |
| 175 | Fibular hypoplasia (HP:0003038) | 1.66267374 |
| 176 | Cerebral palsy (HP:0100021) | 1.66168828 |
| 177 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.66035035 |
| 178 | Elevated alkaline phosphatase (HP:0003155) | 1.64979604 |
| 179 | Axonal loss (HP:0003447) | 1.64724012 |
| 180 | Bicornuate uterus (HP:0000813) | 1.64697705 |
| 181 | Generalized muscle weakness (HP:0003324) | 1.62038929 |
| 182 | Protuberant abdomen (HP:0001538) | 1.61935482 |
| 183 | Abnormality of serum amino acid levels (HP:0003112) | 1.61260949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.21043597 |
| 2 | OXSR1 | 7.48544602 |
| 3 | WNK3 | 7.46235285 |
| 4 | STK39 | 5.19557670 |
| 5 | BCKDK | 3.38171662 |
| 6 | TLK1 | 3.32615735 |
| 7 | ACVR1B | 3.31442695 |
| 8 | GRK1 | 2.67254613 |
| 9 | ADRBK2 | 2.64097045 |
| 10 | STK38L | 2.39634359 |
| 11 | TAOK3 | 2.34202037 |
| 12 | ZAK | 2.24968742 |
| 13 | PDK3 | 2.21981737 |
| 14 | PDK4 | 2.21981737 |
| 15 | BMPR1B | 2.01846041 |
| 16 | WNK1 | 1.95237253 |
| 17 | SGK494 | 1.82634184 |
| 18 | SGK223 | 1.82634184 |
| 19 | FGFR2 | 1.80429285 |
| 20 | NEK1 | 1.79571975 |
| 21 | SIK2 | 1.72066896 |
| 22 | MAPK13 | 1.63230526 |
| 23 | TXK | 1.61640123 |
| 24 | PDK2 | 1.61450492 |
| 25 | CASK | 1.60431944 |
| 26 | MAP4K2 | 1.30674219 |
| 27 | STK38 | 1.25115462 |
| 28 | NUAK1 | 1.24009604 |
| 29 | PIK3CA | 1.21516415 |
| 30 | MST4 | 1.18374580 |
| 31 | NTRK2 | 1.16937698 |
| 32 | MST1R | 1.16450394 |
| 33 | DAPK2 | 1.14969615 |
| 34 | ADRBK1 | 1.12363527 |
| 35 | BLK | 1.10943160 |
| 36 | MAP2K2 | 1.06673917 |
| 37 | SYK | 1.02331632 |
| 38 | DYRK2 | 1.02139922 |
| 39 | ERBB2 | 1.01513657 |
| 40 | AKT3 | 0.99296839 |
| 41 | RPS6KA6 | 0.96317375 |
| 42 | SGK2 | 0.94551650 |
| 43 | MAP3K13 | 0.94459199 |
| 44 | SGK3 | 0.93260125 |
| 45 | GRK6 | 0.92043312 |
| 46 | IKBKB | 0.89718513 |
| 47 | EPHB1 | 0.85994365 |
| 48 | FGFR4 | 0.84820654 |
| 49 | MAP2K6 | 0.83617234 |
| 50 | LRRK2 | 0.81243258 |
| 51 | TNIK | 0.80892246 |
| 52 | RPS6KA2 | 0.75199323 |
| 53 | EPHB2 | 0.74127270 |
| 54 | BTK | 0.73683462 |
| 55 | GSK3A | 0.73360496 |
| 56 | NEK2 | 0.69497825 |
| 57 | TYRO3 | 0.69160379 |
| 58 | LCK | 0.67646747 |
| 59 | PINK1 | 0.67572046 |
| 60 | CHUK | 0.67363119 |
| 61 | CAMKK1 | 0.66551460 |
| 62 | RPS6KL1 | 0.64010590 |
| 63 | RPS6KC1 | 0.64010590 |
| 64 | NLK | 0.63872760 |
| 65 | MAP3K7 | 0.63575425 |
| 66 | TEC | 0.62580710 |
| 67 | GRK7 | 0.62291658 |
| 68 | KIT | 0.60585554 |
| 69 | SGK1 | 0.59522306 |
| 70 | LYN | 0.58757386 |
| 71 | ERN1 | 0.55912343 |
| 72 | CAMK1 | 0.55899871 |
| 73 | MARK2 | 0.55731028 |
| 74 | IKBKE | 0.55730540 |
| 75 | MAP2K7 | 0.55306892 |
| 76 | LATS1 | 0.52371509 |
| 77 | TAOK1 | 0.52221267 |
| 78 | FRK | 0.52117689 |
| 79 | RPS6KA5 | 0.50789069 |
| 80 | MAP3K11 | 0.50618539 |
| 81 | PTK2 | 0.49396644 |
| 82 | PDPK1 | 0.48829904 |
| 83 | MAP3K3 | 0.47614269 |
| 84 | CAMKK2 | 0.47114543 |
| 85 | FER | 0.47010995 |
| 86 | PTK6 | 0.46510904 |
| 87 | FES | 0.45139225 |
| 88 | DYRK1B | 0.44538862 |
| 89 | INSRR | 0.43841441 |
| 90 | PRKCE | 0.43643073 |
| 91 | MUSK | 0.42342815 |
| 92 | NTRK3 | 0.42260052 |
| 93 | HIPK2 | 0.42143230 |
| 94 | PRKAA1 | 0.41675008 |
| 95 | MARK1 | 0.40843978 |
| 96 | GRK5 | 0.40766830 |
| 97 | RIPK4 | 0.40110113 |
| 98 | MAPKAPK3 | 0.39300404 |
| 99 | DYRK3 | 0.37619691 |
| 100 | ABL2 | 0.36561502 |
| 101 | TGFBR2 | 0.36195853 |
| 102 | MAP2K4 | 0.35970964 |
| 103 | TIE1 | 0.35942296 |
| 104 | PDK1 | 0.35843579 |
| 105 | MET | 0.34641815 |
| 106 | MAPK11 | 0.34637320 |
| 107 | IRAK3 | 0.34176844 |
| 108 | PAK4 | 0.33784204 |
| 109 | PRKCI | 0.33154460 |
| 110 | PRKAA2 | 0.31986367 |
| 111 | NME2 | 0.30412922 |
| 112 | MAP3K2 | 0.28877576 |
| 113 | MYLK | 0.28110056 |
| 114 | MAP3K4 | 0.25538282 |
| 115 | PRKD2 | 0.25242516 |
| 116 | PRKCZ | 0.23875614 |
| 117 | STK10 | 0.22624031 |
| 118 | PAK3 | 0.21239928 |
| 119 | IRAK2 | 0.19972103 |
| 120 | NTRK1 | 0.19654308 |
| 121 | NME1 | 0.18021239 |
| 122 | STK11 | 0.17758601 |
| 123 | PTK2B | 0.17170795 |
| 124 | TRIB3 | 0.16787198 |
| 125 | PRKACG | 0.16019802 |
| 126 | PRKCD | 0.15055264 |
| 127 | BMX | 0.14879068 |
| 128 | ITK | 0.14764721 |
| 129 | PRKCH | 0.14196422 |
| 130 | MAPK15 | 0.14181276 |
| 131 | RIPK1 | 0.13694085 |
| 132 | MINK1 | 0.12629954 |
| 133 | JAK2 | 0.12152156 |
| 134 | PRKCA | 0.11512847 |
| 135 | IRAK1 | 0.10408378 |
| 136 | PRKACA | 0.09750756 |
| 137 | AKT2 | 0.08673883 |
| 138 | TNK2 | 0.08197601 |
| 139 | ERBB4 | 0.08053023 |
| 140 | MAP4K1 | 0.07902752 |
| 141 | PRKCQ | 0.07423540 |
| 142 | EPHA4 | 0.07248877 |
| 143 | MAPK12 | 0.06969760 |
| 144 | CSNK1G1 | 0.06891584 |
| 145 | INSR | 0.05541721 |
| 146 | PIM1 | 0.05373858 |
| 147 | CSNK1A1 | 0.05283811 |
| 148 | MAP3K14 | 0.04909454 |
| 149 | MAP2K3 | 0.04333034 |
| 150 | CAMK4 | 0.03289068 |
| 151 | SRC | 0.02821232 |
| 152 | MTOR | 0.02410841 |
| 153 | SCYL2 | 0.01594909 |
| 154 | RPS6KA3 | 0.00693948 |
| 155 | PRKACB | 0.00176109 |
| 156 | CSK | 0.00101945 |
| 157 | CSNK1E | -0.0205462 |
| 158 | CDK5 | -0.0200702 |
| 159 | PRKCG | -0.0162343 |
| 160 | NEK9 | -0.0055301 |
| 161 | CAMK1G | -0.0039619 |
| 162 | ROCK1 | -0.0011755 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.68614626 |
| 2 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.58711871 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.52083679 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.34140809 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25171372 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.16448979 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.14568441 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.14283547 |
| 9 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.81818855 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.81740460 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.69620513 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.59923046 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.47067384 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.43214094 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.33395163 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.30467509 |
| 17 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.27632823 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22688351 |
| 19 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.17377122 |
| 20 | Nicotine addiction_Homo sapiens_hsa05033 | 2.16434963 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.96174777 |
| 22 | Phototransduction_Homo sapiens_hsa04744 | 1.92340061 |
| 23 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88956777 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.88737857 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.87265465 |
| 26 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.86698137 |
| 27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84401819 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.73611337 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.73183195 |
| 30 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.71793927 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.67907922 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.66018356 |
| 33 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65082259 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62848448 |
| 35 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.57029463 |
| 36 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56845435 |
| 37 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.54847403 |
| 38 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.51722021 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48948828 |
| 40 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.43018385 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.37731614 |
| 42 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.36581868 |
| 43 | Morphine addiction_Homo sapiens_hsa05032 | 1.32410081 |
| 44 | Lysine degradation_Homo sapiens_hsa00310 | 1.30760610 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.29086597 |
| 46 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26146518 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.22260077 |
| 48 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.22136463 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.16227919 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16204912 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14653862 |
| 52 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.14256114 |
| 53 | Asthma_Homo sapiens_hsa05310 | 1.13620716 |
| 54 | Other glycan degradation_Homo sapiens_hsa00511 | 1.12780174 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12401228 |
| 56 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.11689227 |
| 57 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.11591523 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.11056994 |
| 59 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.09686242 |
| 60 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.09119153 |
| 61 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07455995 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04498620 |
| 63 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04423520 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 1.03090624 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.99589412 |
| 66 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.98882215 |
| 67 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.98466802 |
| 68 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.96371781 |
| 69 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96090415 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.95943736 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92758170 |
| 72 | Cocaine addiction_Homo sapiens_hsa05030 | 0.92172295 |
| 73 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91594241 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89371285 |
| 75 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88863575 |
| 76 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87152137 |
| 77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85715476 |
| 78 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85404800 |
| 79 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.79969118 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79501102 |
| 81 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.79437818 |
| 82 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.78368377 |
| 83 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77207800 |
| 84 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75886153 |
| 85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.74953589 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.69321701 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68265635 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.67449401 |
| 89 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.66352009 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.64785139 |
| 91 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64367463 |
| 92 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64260407 |
| 93 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63998588 |
| 94 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.63940635 |
| 95 | Allograft rejection_Homo sapiens_hsa05330 | 0.63717000 |
| 96 | Lysosome_Homo sapiens_hsa04142 | 0.62892103 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.62876414 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.62476989 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59900267 |
| 100 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55056309 |
| 101 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52929948 |
| 102 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51958622 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51838370 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51714431 |
| 105 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.49817672 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49278236 |
| 107 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.48604418 |
| 108 | Homologous recombination_Homo sapiens_hsa03440 | 0.48528901 |
| 109 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.48374504 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.48064867 |
| 111 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46479799 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46411549 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.45654461 |
| 114 | Long-term depression_Homo sapiens_hsa04730 | 0.45646385 |
| 115 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.43373761 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42937839 |
| 117 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41539273 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.41083934 |
| 119 | Ribosome_Homo sapiens_hsa03010 | 0.40908371 |
| 120 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40872736 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.39986639 |
| 122 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39953770 |
| 123 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38266758 |
| 124 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.38006656 |
| 125 | Axon guidance_Homo sapiens_hsa04360 | 0.35867579 |
| 126 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.35724709 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.34965373 |
| 128 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.31276117 |
| 129 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.30523990 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.28674596 |
| 131 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28409440 |
| 132 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.26725823 |
| 133 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23553598 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.21862832 |
| 135 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.21397877 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20338803 |
| 137 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.18915118 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.16886465 |
| 139 | Alzheimers disease_Homo sapiens_hsa05010 | 0.16722542 |
| 140 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.16508001 |
| 141 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.16311284 |
| 142 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.14295922 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.14184597 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.12698914 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11624113 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.11491778 |
| 147 | Salivary secretion_Homo sapiens_hsa04970 | 0.10243095 |
| 148 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.09910738 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07266505 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.06123329 |
| 151 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01947536 |
| 152 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.01547730 |
| 153 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01022904 |
| 154 | Huntingtons disease_Homo sapiens_hsa05016 | 0.00784378 |
| 155 | Bladder cancer_Homo sapiens_hsa05219 | -0.0478722 |
| 156 | Hepatitis C_Homo sapiens_hsa05160 | -0.0458190 |
| 157 | Fat digestion and absorption_Homo sapiens_hsa04975 | -0.0387603 |
| 158 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0158137 |

